• Contact Us
Pharmaceuticals & Life Sciences Blogs - VWV

Pharma & Life Sciences

Articles & Blogs Pharma & Life Sciences

The Association of the British Pharmaceutical Industry (ABPI) has issued a policy proposal aimed at supporting the delivery of the NHS 10-Year Plan.

Tuesday, 13 May 2025

The plan is built around three core shifts in care: from hospital to community, from analogue to digital, and from treatment to prevention. These shifts reference the government’s ambition to deliver economic growth through improved health outcomes.

The Association of the British Pharmaceutical Industry (ABPI) has issued a policy proposal aimed at supporting the delivery of the NHS 10-Year Plan.
Read More >

Articles & Blogs Pharma & Life Sciences

NICE introduces promising improvements to the routing criteria for highly specialised technologies designed to treat rare diseases

Tuesday, 13 May 2025

The newly approved routing criteria is hoped to clearly define the circumstances for when highly specialised technologies (HSTs) will be routed to the HST programme which is designed to evaluate technologies for ultra-rare debilitating conditions.

NICE introduces promising improvements to the routing criteria for highly specialised technologies designed to treat rare diseases
Read More >

Articles & Blogs Pharma & Life Sciences

ABPI and UK Government bring forward VPAG pricing review

Thursday, 01 May 2025

The UK Government and the Association of the British Pharmaceutical Industry (ABPI) have agreed to accelerate the planned review of the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG).

ABPI and UK Government bring forward VPAG pricing review
Read More >

Articles & Blogs Pharma & Life Sciences

Sustainability - why this is now crucial for pharma business leaders?

Tuesday, 01 April 2025

Whether your business is in early stage drug discovery and R&D or manufacturing, supply, and distribution, every part of the pharma ecosystem is now under increasing pressure to adopt sustainable practices.

Sustainability - why this is now crucial for pharma business leaders?
Read More >

Articles & Blogs Pharma & Life Sciences

Spending on medicines and medical devices increases but VPAG clawback reach record levels

Tuesday, 01 April 2025

NHS spending on medicines, appliances and medical devices in England hit £19.9bn in 2023/24, with £14.6bn in branded medicine sales. However, the VPAG clawback is meanwhile expected to be an unprecedented £3.5bn in 2025, £1bn more than previously forecast

Spending on medicines and medical devices increases but VPAG clawback reach record levels
Read More >

Articles & Blogs Pharma & Life Sciences

NHS England abolished - what does this mean for pharma?

Tuesday, 01 April 2025

This is not about abolishing the NHS, but a plan to redirect money from bureaucracy to frontline treatments of patients.

NHS England abolished - what does this mean for pharma?
Read More >

Articles & Blogs Pharma & Life Sciences

What remedy is left for contract breach after Court gives wide exclusion of liability for anticipated profits?

Monday, 03 March 2025

Parties to commercial contracts often include exclusion clauses to manage their liability risks. This may contain a list of items such as lost profits, lost revenue, and lost savings among other items.

What remedy is left for contract breach after Court gives wide exclusion of liability for anticipated profits?
Read More >

Articles & Blogs Pharma & Life Sciences

Sustainability trends: key issues shaping the future of Pharmaceuticals and Life Sciences

Monday, 03 March 2025

Leaders in net zero certification, Planet Mark, have recently identified the key sustainability trends for businesses in the UK and beyond. What do these trends mean for the Pharmaceuticals and Life Sciences sector?

Sustainability trends: key issues shaping the future of Pharmaceuticals and Life Sciences
Read More >

Articles & Blogs Pharma & Life Sciences

AI - a tool for sustainability with a resource cost

Thursday, 06 February 2025

AI's sustainability remains a nuanced question, balancing its potential benefits against its environmental costs.

AI - a tool for sustainability with a resource cost
Read More >

Articles & Blogs Pharma & Life Sciences

COP29: What are the key points for the Pharmaceuticals and Life Sciences sector?

Thursday, 06 February 2025

COP29, the 29th Conference of the Parties to the United National Framework Convention on Climate Changes (UNFCCC), was held between 11 and 24 November 2024. We consider the key points for the Pharmaceuticals and Life Sciences sector.

COP29: What are the key points for the Pharmaceuticals and Life Sciences sector?
Read More >

Articles & Blogs Pharma & Life Sciences

Why must Pharma act on sustainability now?

Thursday, 06 February 2025

Even only a couple of years ago, sustainability was seen as something that would be a 'nice to have'. No more. It has risen right up to the top of the agenda as a leading issue for pharma leaders. Why? The pressure has been coming from lots of angles.

Why must Pharma Act on sustainability now?
Read More >

Articles & Blogs Pharma & Life Sciences

What can we expect from the new era of clinical trials in the UK?

Thursday, 23 January 2025

It is hoped that changes to legislation on clinical trials in the UK will quicken the trial approvals process and foster innovation in trial design without compromising patient safety. The amending legislation has been made and will apply in early 2026.

What can we expect from the new era of clinical trials in the UK?
Read More >

Articles & Blogs Pharma & Life Sciences

Changes to UK medical devices regulation: What is on the horizon for 2025?

Thursday, 23 January 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) recently published a roadmap which sets out the revised timeline for implementing reforms to the UK's medical devices regulatory framework.

Changes to UK medical devices regulation: What is on the horizon for 2025?
Read More >

Articles & Blogs Pharma & Life Sciences

Economic Crime and Corporate Transparency Act 2023 - managing fraud risk and the failure to prevent offence

Thursday, 23 January 2025

The Economic Crime and Corporate Transparency Act 2023 (the Act) is a pivotal piece of legislation, aimed at bolstering the UK's defences against fraud.

Economic Crime and Corporate Transparency Act 2023 - managing fraud risk and the failure to prevent offence
Read More >

Articles & Blogs Pharma & Life Sciences

Pharmaceuticals and Life Sciences: what will 2025 bring?

Thursday, 12 December 2024

As things quieten down for the end of the year (ha ha, one day maybe but not 2024!), it is good to reflect on what is next. In this article, we have pointed towards a few key developments to watch out for in 2025.

Pharmaceuticals and Life Sciences: what will 2025 bring?
Read More >